vs
Side-by-side financial comparison of Dexcom (DXCM) and ENTEGRIS INC (ENTG). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $823.9M, roughly 1.5× ENTEGRIS INC). Dexcom runs the higher net margin — 21.2% vs 6.0%, a 15.2% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -3.1%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 3.4%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Entegris, Inc. is a supplier of materials for the semiconductor and other high-tech industries. Entegris has approximately 8,000 employees throughout its global operations. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. The company’s corporate headquarters are in Billerica, Massachusetts.
DXCM vs ENTG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $823.9M |
| Net Profit | $267.3M | $49.4M |
| Gross Margin | 62.9% | 43.8% |
| Operating Margin | 25.6% | 12.7% |
| Net Margin | 21.2% | 6.0% |
| Revenue YoY | 21.6% | -3.1% |
| Net Profit YoY | 153.6% | -51.7% |
| EPS (diluted) | $0.67 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $823.9M | ||
| Q3 25 | $1.2B | $807.1M | ||
| Q2 25 | $1.2B | $792.4M | ||
| Q1 25 | $1.0B | $773.2M | ||
| Q4 24 | $1.1B | $849.8M | ||
| Q3 24 | $994.2M | $807.7M | ||
| Q2 24 | $1.0B | $812.7M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $49.4M | ||
| Q3 25 | $283.8M | $70.5M | ||
| Q2 25 | $179.8M | $52.8M | ||
| Q1 25 | $105.4M | $62.9M | ||
| Q4 24 | $151.7M | $102.2M | ||
| Q3 24 | $134.6M | $77.6M | ||
| Q2 24 | $143.5M | $67.7M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 43.8% | ||
| Q3 25 | 60.5% | 43.5% | ||
| Q2 25 | 59.5% | 44.4% | ||
| Q1 25 | 56.9% | 46.1% | ||
| Q4 24 | 58.9% | 45.6% | ||
| Q3 24 | 59.7% | 46.0% | ||
| Q2 24 | 62.4% | 46.2% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 12.7% | ||
| Q3 25 | 20.1% | 15.2% | ||
| Q2 25 | 18.4% | 13.4% | ||
| Q1 25 | 12.9% | 15.8% | ||
| Q4 24 | 17.0% | 17.6% | ||
| Q3 24 | 15.3% | 16.9% | ||
| Q2 24 | 15.7% | 16.0% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 6.0% | ||
| Q3 25 | 23.5% | 8.7% | ||
| Q2 25 | 15.5% | 6.7% | ||
| Q1 25 | 10.2% | 8.1% | ||
| Q4 24 | 13.6% | 12.0% | ||
| Q3 24 | 13.5% | 9.6% | ||
| Q2 24 | 14.3% | 8.3% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.33 | ||
| Q3 25 | $0.70 | $0.46 | ||
| Q2 25 | $0.45 | $0.35 | ||
| Q1 25 | $0.27 | $0.41 | ||
| Q4 24 | $0.37 | $0.67 | ||
| Q3 24 | $0.34 | $0.51 | ||
| Q2 24 | $0.35 | $0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $360.4M |
| Total DebtLower is stronger | — | $3.7B |
| Stockholders' EquityBook value | $2.7B | $4.0B |
| Total Assets | $6.3B | $8.4B |
| Debt / EquityLower = less leverage | — | 0.94× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $360.4M | ||
| Q3 25 | $1.8B | $399.8M | ||
| Q2 25 | $1.2B | $376.8M | ||
| Q1 25 | $904.9M | $340.9M | ||
| Q4 24 | $606.1M | $329.2M | ||
| Q3 24 | $621.2M | $432.1M | ||
| Q2 24 | $939.2M | $320.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.7B | ||
| Q3 25 | — | $3.8B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.0B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $4.1B | ||
| Q2 24 | — | $4.1B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $4.0B | ||
| Q3 25 | $2.7B | $3.9B | ||
| Q2 25 | $2.6B | $3.8B | ||
| Q1 25 | $2.3B | $3.7B | ||
| Q4 24 | $2.1B | $3.7B | ||
| Q3 24 | $2.0B | $3.6B | ||
| Q2 24 | $2.4B | $3.5B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $8.4B | ||
| Q3 25 | $7.5B | $8.4B | ||
| Q2 25 | $7.3B | $8.4B | ||
| Q1 25 | $6.8B | $8.4B | ||
| Q4 24 | $6.5B | $8.4B | ||
| Q3 24 | $6.4B | $8.5B | ||
| Q2 24 | $6.8B | $8.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.94× | ||
| Q3 25 | — | 0.99× | ||
| Q2 25 | — | 1.05× | ||
| Q1 25 | — | 1.06× | ||
| Q4 24 | — | 1.08× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.18× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $192.0M |
| Free Cash FlowOCF − Capex | — | $134.0M |
| FCF MarginFCF / Revenue | — | 16.3% |
| Capex IntensityCapex / Revenue | — | 7.0% |
| Cash ConversionOCF / Net Profit | — | 3.89× |
| TTM Free Cash FlowTrailing 4 quarters | — | $396.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $192.0M | ||
| Q3 25 | $659.9M | $249.5M | ||
| Q2 25 | $303.0M | $113.5M | ||
| Q1 25 | $183.8M | $140.4M | ||
| Q4 24 | $301.4M | $176.1M | ||
| Q3 24 | $199.5M | $197.2M | ||
| Q2 24 | $279.4M | $111.2M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $134.0M | ||
| Q3 25 | $579.4M | $182.8M | ||
| Q2 25 | $208.9M | $47.0M | ||
| Q1 25 | $96.8M | $32.4M | ||
| Q4 24 | $176.8M | $68.6M | ||
| Q3 24 | $88.3M | $115.0M | ||
| Q2 24 | $213.3M | $51.9M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 16.3% | ||
| Q3 25 | 47.9% | 22.6% | ||
| Q2 25 | 18.1% | 5.9% | ||
| Q1 25 | 9.3% | 4.2% | ||
| Q4 24 | 15.9% | 8.1% | ||
| Q3 24 | 8.9% | 14.2% | ||
| Q2 24 | 21.2% | 6.4% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 7.0% | ||
| Q3 25 | 6.7% | 8.3% | ||
| Q2 25 | 8.1% | 8.4% | ||
| Q1 25 | 8.4% | 14.0% | ||
| Q4 24 | 11.2% | 12.7% | ||
| Q3 24 | 11.2% | 10.2% | ||
| Q2 24 | 6.6% | 7.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 3.89× | ||
| Q3 25 | 2.33× | 3.54× | ||
| Q2 25 | 1.69× | 2.15× | ||
| Q1 25 | 1.74× | 2.23× | ||
| Q4 24 | 1.99× | 1.72× | ||
| Q3 24 | 1.48× | 2.54× | ||
| Q2 24 | 1.95× | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
ENTG
| Fabs | $516.3M | 63% |
| Equipment And Engineering | $121.8M | 15% |
| Chemical And Materials | $83.8M | 10% |
| Other | $61.7M | 7% |
| Non Semi | $40.3M | 5% |
